Reverie Labs
ClosedEngineering next-generation, brain-penetrant cancer therapies.
Cambridge, United States · Founded 2017 · $32.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Website
- reverielabs.com
- Total Funding
- $32.0M
- Last Round
- $7.0M Seed
- Rounds
- 2
About
Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.
Summary
Reverie Labs is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $32.0M in total across 2 rounds. Investors include General Catalyst, Ridgeback Capital and BoxGroup.
Tech & App Stack
20 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2024
Sign up to see all 3 rounds
Seed through Acqui-hire — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/reverie-labs"><img src="https://indexed.vc/api/badge/company/reverie-labs" alt="Reverie Labs on Indexed.vc" width="260" height="76" /></a>